1. Home
  2. ETON vs VSTS Comparison

ETON vs VSTS Comparison

Compare ETON & VSTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETON
  • VSTS
  • Stock Information
  • Founded
  • ETON 2017
  • VSTS 1936
  • Country
  • ETON United States
  • VSTS United States
  • Employees
  • ETON 31
  • VSTS N/A
  • Industry
  • ETON Biotechnology: Pharmaceutical Preparations
  • VSTS
  • Sector
  • ETON Health Care
  • VSTS
  • Exchange
  • ETON Nasdaq
  • VSTS Nasdaq
  • Market Cap
  • ETON 498.8M
  • VSTS 572.2M
  • IPO Year
  • ETON 2018
  • VSTS N/A
  • Fundamental
  • Price
  • ETON $18.25
  • VSTS $5.12
  • Analyst Decision
  • ETON Strong Buy
  • VSTS Sell
  • Analyst Count
  • ETON 3
  • VSTS 4
  • Target Price
  • ETON $29.67
  • VSTS $9.13
  • AVG Volume (30 Days)
  • ETON 261.2K
  • VSTS 2.1M
  • Earning Date
  • ETON 11-06-2025
  • VSTS 11-20-2025
  • Dividend Yield
  • ETON N/A
  • VSTS 1.34%
  • EPS Growth
  • ETON N/A
  • VSTS N/A
  • EPS
  • ETON N/A
  • VSTS N/A
  • Revenue
  • ETON $58,181,000.00
  • VSTS $2,707,109,000.00
  • Revenue This Year
  • ETON $105.25
  • VSTS N/A
  • Revenue Next Year
  • ETON $40.84
  • VSTS $0.29
  • P/E Ratio
  • ETON N/A
  • VSTS N/A
  • Revenue Growth
  • ETON 85.40
  • VSTS N/A
  • 52 Week Low
  • ETON $8.24
  • VSTS $3.98
  • 52 Week High
  • ETON $23.00
  • VSTS $17.83
  • Technical
  • Relative Strength Index (RSI)
  • ETON 46.28
  • VSTS 58.86
  • Support Level
  • ETON $18.00
  • VSTS $4.69
  • Resistance Level
  • ETON $18.92
  • VSTS $5.41
  • Average True Range (ATR)
  • ETON 0.87
  • VSTS 0.20
  • MACD
  • ETON -0.12
  • VSTS 0.03
  • Stochastic Oscillator
  • ETON 40.66
  • VSTS 72.93

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About VSTS Vestis Corporation

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

Share on Social Networks: